Skip to main content
| News

Roche tests able to detect Omicron

03.12.2021

The Roche subsidiary TIB Molbiol has developed new coronavirus testing kits that can also detect the new Omicron variant of the disease. These tests will serve research purposes. However, Roche diagnosis tests could also be used to detect Omicron infections in the future.

Roche logo on a building at the headquarters in Basel (img: Roche)

TIB Molbiol Syntheselabor GmbH, which was only taken over by Roche at the start of December, has developed a trio of new coronavirus tests, further details of which can be found in a press release issued by the Basel-based life sciences group. These tests are designed to uncover mutations seen in the new Omicron variant and are based on the quantitative polymerase chain reaction (PCR) method, which delivers the relevant results in real time. In presenting its new testing kits, Roche explains that they are among the first to specify the mutations of the recently discovered Omicron variant.

Employees at TIB Molbiol worked around the clock to develop the tests after the news broke regarding Omicron, explains Thomas Schinecker, CEO Roche Diagnostics. The tests could now help to improve understanding in connection with how Omicron spreads and behaves. This will benefit ongoing research and could accelerate the development of new treatments and vaccines.

While the new tests are to be exclusively used for research purposes, Roche also offers several coronavirus tests for diagnostic purposes. The SARS-CoV-2 Variant Set 1 test (RUO) is able to detect one of the mutations observed in the Omicron variants, meaning it can be used to diagnose Omicron cases, the press release explains.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Sustainability

Evolva launches new line for manufacturers of personal care products

Evolva, a manufacturer of active ingredients based in Reinach in the canton of Basel-Landschaft, will be presenting its new product...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Record figure for startups in the Basel Area

Basel Area Business & Innovation has supported a record number of 96 company startups in 2022. The number of settlements...

Read More
Noema Pharma raises 103 million Swiss francs from investors
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Noema Pharma raises 103 million Swiss francs from investors

Noema Pharma has raised a total of 103 million Swiss francs as part of an oversubscribed Series B financing round....

Read More
Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Why CDMO companies choose the Basel Area as their location

Originally, this article was published by the US magazine Outsourced Pharma under the title "Why Location Matters". The article highlights...

Read More
Basel Area Business & Innovation, Innovation, Invest

Basel still the most attractive small city for business in Europe

As with last year, Basel once again features among the most attractive locations in Europe for investments. It was ranked...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Ariceum Therapeutics establishes subsidiary in Basel

The German life sciences firm Ariceum Therapeutics has established a subsidiary in Basel. This company has received support from Basel...

Read More
1 2 3 61

Do you have a question? We'd like to hear from you.